Anti-gene padlocks eliminate Escherichia coli based on their genotype

Chanjuan Shi, Antony R. Parker, Li Hua, Craig N. Morrell, Soo Chin Lee, Viswanath Bandaru, J. Stephen Dumler, Tzyy Choou Wu, James Eshleman

Research output: Contribution to journalArticle

Abstract

Objectives: Several therapeutic strategies that target nucleic acids exist; however, most approaches target messenger RNA, rather than genomic DNA. We describe a novel oligonucleotide-based strategy, called anti-gene padlocks (AGPs), which eliminate Escherichia coli based on their genotype. Methods: The strategy employs an oligonucleotide with adouble hairpin structure where both strands of the AGP are complementary to both strands of a target gene. We tested AGPs for in vitro binding and inhibition of DNA polymerization. AGPs were electroporated into bacterial cells with and without gene targets along with an ampicillin resistance plasmid, and cell survival was measured. Results: In vitro, AGPs bound the DNA target in a sequence-dependent fashion and inhibited DNA synthesis. When transformed into bacterial cells containing 10, 20 or 30 bp lacZ or 20 bp proA DNA targets in their genomes, AGPs selectively killed or otherwise inhibited growth of these cells, while those lacking the target demonstrated little, if any, toxicity. A single transformation resulted in ∼30% to 40% loss of target-bearing cells. Structure-function experiments were performed to define essential AGP requirements. Conclusions: These results suggest that AGPs may be a useful tool to eliminate specific cell populations.

Original languageEnglish (US)
Pages (from-to)262-272
Number of pages11
JournalThe Journal of antimicrobial chemotherapy
Volume61
Issue number2
DOIs
StatePublished - Feb 2008

Fingerprint

Genotype
Escherichia coli
Genes
DNA
Oligonucleotides
Ampicillin Resistance
Essential Genes
Polymerization
Nucleic Acids
Cell Survival
Plasmids
Genome
Messenger RNA
Growth
Population

Keywords

  • Antibiotics
  • Antimicrobial agents
  • Gene targeting
  • Novel therapeutics
  • Oligonucleotide
  • Padlock probes

ASJC Scopus subject areas

  • Pharmacology
  • Microbiology

Cite this

Anti-gene padlocks eliminate Escherichia coli based on their genotype. / Shi, Chanjuan; Parker, Antony R.; Hua, Li; Morrell, Craig N.; Lee, Soo Chin; Bandaru, Viswanath; Dumler, J. Stephen; Wu, Tzyy Choou; Eshleman, James.

In: The Journal of antimicrobial chemotherapy, Vol. 61, No. 2, 02.2008, p. 262-272.

Research output: Contribution to journalArticle

Shi, C, Parker, AR, Hua, L, Morrell, CN, Lee, SC, Bandaru, V, Dumler, JS, Wu, TC & Eshleman, J 2008, 'Anti-gene padlocks eliminate Escherichia coli based on their genotype', The Journal of antimicrobial chemotherapy, vol. 61, no. 2, pp. 262-272. https://doi.org/10.1093/jac/dkm482
Shi, Chanjuan ; Parker, Antony R. ; Hua, Li ; Morrell, Craig N. ; Lee, Soo Chin ; Bandaru, Viswanath ; Dumler, J. Stephen ; Wu, Tzyy Choou ; Eshleman, James. / Anti-gene padlocks eliminate Escherichia coli based on their genotype. In: The Journal of antimicrobial chemotherapy. 2008 ; Vol. 61, No. 2. pp. 262-272.
@article{4ddffeacb1e6461a9286d83a9acc5549,
title = "Anti-gene padlocks eliminate Escherichia coli based on their genotype",
abstract = "Objectives: Several therapeutic strategies that target nucleic acids exist; however, most approaches target messenger RNA, rather than genomic DNA. We describe a novel oligonucleotide-based strategy, called anti-gene padlocks (AGPs), which eliminate Escherichia coli based on their genotype. Methods: The strategy employs an oligonucleotide with adouble hairpin structure where both strands of the AGP are complementary to both strands of a target gene. We tested AGPs for in vitro binding and inhibition of DNA polymerization. AGPs were electroporated into bacterial cells with and without gene targets along with an ampicillin resistance plasmid, and cell survival was measured. Results: In vitro, AGPs bound the DNA target in a sequence-dependent fashion and inhibited DNA synthesis. When transformed into bacterial cells containing 10, 20 or 30 bp lacZ or 20 bp proA DNA targets in their genomes, AGPs selectively killed or otherwise inhibited growth of these cells, while those lacking the target demonstrated little, if any, toxicity. A single transformation resulted in ∼30{\%} to 40{\%} loss of target-bearing cells. Structure-function experiments were performed to define essential AGP requirements. Conclusions: These results suggest that AGPs may be a useful tool to eliminate specific cell populations.",
keywords = "Antibiotics, Antimicrobial agents, Gene targeting, Novel therapeutics, Oligonucleotide, Padlock probes",
author = "Chanjuan Shi and Parker, {Antony R.} and Li Hua and Morrell, {Craig N.} and Lee, {Soo Chin} and Viswanath Bandaru and Dumler, {J. Stephen} and Wu, {Tzyy Choou} and James Eshleman",
year = "2008",
month = "2",
doi = "10.1093/jac/dkm482",
language = "English (US)",
volume = "61",
pages = "262--272",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Anti-gene padlocks eliminate Escherichia coli based on their genotype

AU - Shi, Chanjuan

AU - Parker, Antony R.

AU - Hua, Li

AU - Morrell, Craig N.

AU - Lee, Soo Chin

AU - Bandaru, Viswanath

AU - Dumler, J. Stephen

AU - Wu, Tzyy Choou

AU - Eshleman, James

PY - 2008/2

Y1 - 2008/2

N2 - Objectives: Several therapeutic strategies that target nucleic acids exist; however, most approaches target messenger RNA, rather than genomic DNA. We describe a novel oligonucleotide-based strategy, called anti-gene padlocks (AGPs), which eliminate Escherichia coli based on their genotype. Methods: The strategy employs an oligonucleotide with adouble hairpin structure where both strands of the AGP are complementary to both strands of a target gene. We tested AGPs for in vitro binding and inhibition of DNA polymerization. AGPs were electroporated into bacterial cells with and without gene targets along with an ampicillin resistance plasmid, and cell survival was measured. Results: In vitro, AGPs bound the DNA target in a sequence-dependent fashion and inhibited DNA synthesis. When transformed into bacterial cells containing 10, 20 or 30 bp lacZ or 20 bp proA DNA targets in their genomes, AGPs selectively killed or otherwise inhibited growth of these cells, while those lacking the target demonstrated little, if any, toxicity. A single transformation resulted in ∼30% to 40% loss of target-bearing cells. Structure-function experiments were performed to define essential AGP requirements. Conclusions: These results suggest that AGPs may be a useful tool to eliminate specific cell populations.

AB - Objectives: Several therapeutic strategies that target nucleic acids exist; however, most approaches target messenger RNA, rather than genomic DNA. We describe a novel oligonucleotide-based strategy, called anti-gene padlocks (AGPs), which eliminate Escherichia coli based on their genotype. Methods: The strategy employs an oligonucleotide with adouble hairpin structure where both strands of the AGP are complementary to both strands of a target gene. We tested AGPs for in vitro binding and inhibition of DNA polymerization. AGPs were electroporated into bacterial cells with and without gene targets along with an ampicillin resistance plasmid, and cell survival was measured. Results: In vitro, AGPs bound the DNA target in a sequence-dependent fashion and inhibited DNA synthesis. When transformed into bacterial cells containing 10, 20 or 30 bp lacZ or 20 bp proA DNA targets in their genomes, AGPs selectively killed or otherwise inhibited growth of these cells, while those lacking the target demonstrated little, if any, toxicity. A single transformation resulted in ∼30% to 40% loss of target-bearing cells. Structure-function experiments were performed to define essential AGP requirements. Conclusions: These results suggest that AGPs may be a useful tool to eliminate specific cell populations.

KW - Antibiotics

KW - Antimicrobial agents

KW - Gene targeting

KW - Novel therapeutics

KW - Oligonucleotide

KW - Padlock probes

UR - http://www.scopus.com/inward/record.url?scp=38349156084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349156084&partnerID=8YFLogxK

U2 - 10.1093/jac/dkm482

DO - 10.1093/jac/dkm482

M3 - Article

C2 - 18156610

AN - SCOPUS:38349156084

VL - 61

SP - 262

EP - 272

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 2

ER -